Last reviewed · How we verify

NCT05755516

Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms

Completed NA Last updated 2 January 2026
What this trial tests

NA trial testing Self-expanding Intracranial Stent (Tonbridge) in Intracranial Aneurysm in 204 participants. Completed in 13 December 2024.

Timeline
14 February 2023
Primary endpoint
10 March 2024
13 December 2024

Quick facts

Lead sponsorTon-Bridge Medical Tech. Co., Ltd
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment204
Start date14 February 2023
Primary completion10 March 2024
Estimated completion13 December 2024
Sites14 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Ton-Bridge Medical Tech. Co., Ltd

Who can join

Adults 18 to 80, any sex, with Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the efficacy and safety of Self-expanding Intracranial Stent (Tonbridge), by comparing the data obtained from Self-expanding Intracranial Stent (Zhuhai Tonbridge Medical Tech. Co., Ltd.) and LVIS/LVIS Jr. (MicroVention Europe SARL) for endovascular treatment of intracranial aneurysms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intracranial Aneurysm

Currently open trials in the same condition.

Other Ton-Bridge Medical Tech. Co., Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05755516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing